Apathy and Attentional Biases in Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 51, Issue 3, 2016, Pages 837-846

  Chau, Sarah A ^a,b   Chung, Jonathan ^b,c   Herrmann, Nathan ^a,b   Eizenman, Moshe ^b,c,d   Lanctôt, Krista L ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alzheimer's disease; apathy; attention; cognition; eye movements

Indexed keywords

AGED; ALZHEIMER DISEASE; APATHY; APATHY EVALUATION SCALE; ARTICLE; ATTENTIONAL BIAS; BEHAVIOR; BEHAVIOR ASSESSMENT; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EMOTION; FEMALE; GENERAL MENTAL DISEASE ASSESSMENT; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHIATRIC INVENTORY; PRIORITY JOURNAL; TIME; EYE MOVEMENT; NEUROPSYCHOLOGICAL TEST; OCULOGRAPHY; PATHOPHYSIOLOGY; PERCEPTION; PHOTOSTIMULATION; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

AGED; ALZHEIMER DISEASE; APATHY; ATTENTIONAL BIAS; COGNITION; CROSS-SECTIONAL STUDIES; EMOTIONS; EYE MOVEMENT MEASUREMENTS; EYE MOVEMENTS; FEMALE; HUMANS; LINEAR MODELS; MALE; NEUROPSYCHOLOGICAL TESTS; PHOTIC STIMULATION; SEVERITY OF ILLNESS INDEX; SOCIAL PERCEPTION;

EID: 84963751429     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-151026     Document Type: Article

References (71)

1. Mulin E, Leone E, Dujardin K, Delliaux M, Leentjens A, Nobili F, Dessi B, Tible O, Aguera-Ortiz L, Osorio RS, Yessavage J, Dachevsky D, Verhey FR, Jentoft AJ, Blanc O, Llorca PM, Robert PH (2011) Diagnostic criteria for apathy in clinical practice. Int J Geriatr Psychiatry 26, 158-165.
2. Zhao H, Zhao Z, Huang L, Preter M (2012) Diagnosis and assessment of apathy in Chinese patients with Alzheimer's disease. J Psychosom Res 72, 405-407.
3. TatschMF, Bottino CM, Azevedo D, Hototian SR, Moscoso MA, Folquitto JC, Scalco AZ, LouzaMR(2006) Neuropsychiatric symptoms in Alzheimer disease and cognitively impaired, nondemented elderly from a community-based sample in Brazil: Prevalence and relationship with dementia severity. Am J Geriatr Psychiatry 14, 438-445.
4. Srikanth S, Nagaraja AV, Ratnavalli E (2005) Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia. J Neurol Sci 236, 43-48.
5. Chase TN (2011) Apathy in neuropsychiatric disease: Diagnosis, pathophysiology, and treatment. Neurotox Res 19, 266-278.
6. Zuidema SU, Derksen E, Verhey FR, Koopmans RT (2007) Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia. Int J Geriatr Psychiatry 22, 632-638.
7. Margallo-Lana M, Swann A, O'Brien J, Fairbairn A, Reichelt K, Potkins D, Mynt P, Ballard C (2001) Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments. Int J Geriatr Psychiatry 16, 39-44.
8. Wood S, Cummings JL, Hsu MA, Barclay T, WheatleyMV, Yarema KT, Schnelle JF (2000) The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement. Am J Geriatr Psychiatry 8 75-83.
9. Volicer L, Frijters DH, van der Steen JT (2013) Apathy and weight loss in nursing home residents: Longitudinal study. J Am Med Dir Assoc 14, 417-420.
10. Ishii S,Weintraub N, Mervis JR (2009) Apathy: A common psychiatric syndrome in the elderly. J Am Med Dir Assoc 10, 381-393.
11. Lechowski L, Benoit M, Chassagne P, Vedel I, Tortrat D, Teillet L, Vellas B (2009) Persistent apathy in Alzheimer's disease as an independent factor of rapid functional decline: The REAL longitudinal cohort study. Int J Geriatr Psychiatry 24, 341-346.
12. Starkstein SE, Jorge R, Mizrahi R, Robinson RG (2006) A prospective longitudinal study of apathy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 77, 8-11.
13. Wadsworth LP, Lorius N, Donovan NJ, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Marshall GA (2012) Neuropsychiatric Symptoms and Global Functional Impairment along the Alzheimer's Continuum. Dement Geriatr Cogn Disord 34, 96-111.
14. You SC, Walsh CM, Chiodo LA, Ketelle R, Miller BL, Kramer JH (2015) Neuropsychiatric symptoms predict functional status in Alzheimer's Disease. J Alzheimers Dis 48, 863-869.
15. Kaufer DI, Cummings JL, Christine D, Bray T, Castellon S, Masterman D, MacMillan A, Ketchel P, DeKosky ST (1998) Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: The Neuropsychiatric Inventory Caregiver Distress Scale. J Am Geriatr Soc 46, 210-215.
16. Benoit M, Andrieu S, Lechowski L, Gillette-Guyonnet S, Robert PH, Vellas B (2008) Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription. Int J Geriatr Psychiatry 23, 409-414.
17. Pang FC, Chow TW, Cummings JL, Leung VP, Chiu HF, Lam LC, Chen QL, Tai CT, Chen LW, Wang SJ, Fuh JL (2002) Effect of neuropsychiatric symptoms of Alzheimer's disease on Chinese and American caregivers. Int J Geriatr Psychiatry 17, 29-34.
18. vanDijk PT, Dippel DW, Habbema JD (1994) A behavioral rating scale as a predictor for survival of demented nursing home patients. Arch Gerontol Geriatr 18, 101-113.
19. Spalletta G, Long JD, Robinson RG, Trequattrini A, Pizzoli S, Caltagirone C, Orfei MD (2015) Longitudinal neuropsychiatric predictors of death in Alzheimer's disease. J Alzheimers Dis 48, 627-636.
20. Mitchell RA, Herrmann N, Lanctôt KL (2010) The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease. CNS Neurosci Ther 17, 411-427.
21. Herrmann N, Rothenburg LS, Black SE, Ryan M, Liu BA, Busto UE, LanctôtKL(2008) Methylphenidate for the treatment of apathy in Alzheimer disease: Prediction of response using dextroamphetamine challenge. J Clin Psychopharmacol 28, 296-301.
22. Rosenberg PB, Lanctot KL, Drye LT, Herrmann N, Scherer RW, Bachman DL, Mintzer JE, Investigators A (2013) Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: A randomized, placebo-controlled trial. J Clin Psychiatry 74, 810-816.
23. Padala PR, Burke WJ, Shostrom VK, Bhatia SC, Wengel SP, Potter JF, Petty F (2010) Methylphenidate for apathy and functional status in dementia of the Alzheimer type. Am J Geriatr Psychiatry 18, 371-374.
24. Marin RS (1991) Apathy: A neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 3, 243-254.
25. Stanton BR, Leigh PN, Howard RJ, Barker GJ, Brown RG (2013) Behavioural and emotional symptoms of apathy are associated with distinct patterns of brain atrophy in neurodegenerative disorders. J Neurol 260, 2481-2490.
26. Benoit M, Clairet S, Koulibaly PM, Darcourt J, Robert PH (2004) Brain perfusion correlates of the apathy inventory dimensions of Alzheimer's disease. Int J Geriatr Psychiatry 19, 864-869.
27. Geda YE, Schneider LS, Gitlin LN, Miller DS, Smith GS, Bell J, Evans J, Lee M, Porsteinsson A, Lanctot KL, Rosenberg PB, Sultzer DL, Francis PT, Brodaty H, Padala PP, Onyike CU, Ortiz LA, Ancoli-Israel S, Bliwise DL, Martin JL, Vitiello MV, Yaffe K, Zee PC, Herrmann N, Sweet RA, Ballard C, Khin NA, Alfaro C, Murray PS, Schultz S, Lyketsos CG, Neuropsychiatric Syndromes Professional Interest Area of I (2013) Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future. Alzheimers Dement 9, 602-608.
28. Lanctôt KL, Chau SA, Herrmann N, Drye LT, Rosenberg PB, SchererRW, Black SE,VaidyaV, Bachman DL, Mintzer JE (2014) Effect of methylphenidate on attention in apatheticADpatients in a randomized, placebo-controlled trial. Int Psychogeriatr 26, 239-246.
29. Lanctôt KL, Moosa S, Herrmann N, Leibovitch FS, Rothenburg L, Cotter A, Black SE (2007)ASPECT study of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord 24, 65-72.
30. Apostolova LG, Akopyan GG, Partiali N, Steiner CA, Dutton RA, Hayashi KM, Dinov ID, Toga AW, Cummings JL, Thompson PM (2007) Structural correlates of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord 24, 91-97.
31. Mogg K, Millar N, Bradley BP (2000) Biases in eye movements to threatening facial expressions in generalized anxiety disorder and depressive disorder. J Abnorm Psychol 109, 695-704.
32. Koster EH, De Raedt R, Goeleven E, Franck E, Crombez G (2005) Mood-congruent attentional bias in dysphoria: Maintained attention to and impaired disengagement from negative information. Emotion 5, 446-455.
33. Eizenman M, Yu LH, Grupp L, Eizenman E, Ellenbogen M, Gemar M, Levitan RD (2003) A naturalistic visual scanning approach to assess selective attention in major depressive disorder. Psychiatry Res 118, 117-128.
34. Kellough JL, Beevers CG, Ellis AJ, Wells TT (2008) Time course of selective attention in clinically depressed young adults: An eye tracking study. Behav Res Ther 46, 1238-1243.
35. (2013) Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, Arlington, VA.
36. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
37. Molloy DW, Alemayehu E, Roberts R (1991) Reliability of a Standardized Mini-Mental State Examination compared with the traditional Mini-Mental State Examination. Am J Psychiatry 148, 102-105.
38. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 44, 2308-2314.
39. Conners CK (2000) Continuous Performance Test (CPT II) Computer Program for Windows Technical Guide and Software Manual. Multi-Health Systems, Inc., North Tonawanda, NY.
40. FolsteinMF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
41. Marin RS, Biedrzycki RC, Firinciogullari S (1991) Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 38, 143-162.
42. Vilalta-Franch J, Calvo-Perxas L, Garre-Olmo J, Turro-Garriga O, Lopez-Pousa S (2013) Apathy syndrome in Alzheimer's disease epidemiology: Prevalence, incidence, persistence, and risk and mortality factors. J Alzheimers Dis 33, 535-543.
43. Onyike CU, Sheppard JM, Tschanz JT, Norton MC, Green RC, SteinbergM,Welsh-Bohmer KA, Breitner JC, Lyketsos CG (2007) Epidemiology of apathy in older adults: The Cache County Study. Am J Geriatr Psychiatry 15, 365-375.
44. Waldemar G, Gauthier S, Jones R,Wilkinson D, Cummings J, Lopez O, Zhang R, Xu Y, Sun Y, Knox S, Richardson S, Mackell J (2011) Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease. Int J Geriatr Psychiatry 26, 150-157.
45. Clarke DE, Reekum R, Simard M, Streiner DL, Freedman M, Conn D (2007) Apathy in dementia: An examination of the psychometric properties of the apathy evaluation scale. J Neuropsychiatry Clin Neurosci 19, 57-64.
46. Guestrin ED, Eizenman M (2007) Remote point-of-gaze estimation with free head movements requiring a singlepoint calibration. Conf Proc IEEE Eng Med Biol Soc 2007, 4556-4560.
47. Hannula DE, Althoff RR, Warren DE, Riggs L, Cohen NJ, Ryan JD (2010) Worth a glance: Using eye movements to investigate the cognitive neuroscience of memory. Front Hum Neurosci 4, 166.
48. Pinhas L, Fok KH, Chen A, Lam E, Schachter R, Eizenman O, Grupp L, Eizenman M (2014) Attentional biases to body shape images in adolescents with anorexia nervosa: An exploratory eye-tracking study. Psychiatry Res 220, 519-526.
49. Berridge KC, Robinson TE (1998) What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28, 309-369.
50. Alcaro A, Huber R, Panksepp J (2007) Behavioral functions of the mesolimbic dopaminergic system: An affective neuroethological perspective. Brain Res Rev 56, 283-321.
51. Nieoullon A, CoquerelA(2003) Dopamine:Akey regulator to adapt action, emotion, motivation and cognition. Curr Opin Neurol 16(Suppl 2), S3-S9.
52. Koob GF (1996) Hedonic valence, dopamine and motivation. Mol Psychiatry 1, 186-189.
53. Wise RA (2004) Dopamine, learning and motivation. Nat Rev Neurosci 5, 483-494.
54. David R, Koulibaly M, Benoit M, Garcia R, Caci H, Darcourt J, Robert P (2008) Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases A SPECT study with partial volume effect correction. Clin Neurol Neurosurg 110, 19-24.
55. Vasquez BP, Buck BH, Black SE, Leibovitch FS, Lobaugh NJ, Caldwell CB, Behrmann M (2011) Visual attention deficits in Alzheimer's disease: Relationship to HMPAO SPECT cortical hypoperfusion. Neuropsychologia 49, 1741-1750.
56. Nakaaki S, Murata Y, Sato J, Shinagawa Y, Tatsumi H, Hirono N, Furukawa TA (2007) Greater impairment of ability in the divided attention task is seen in Alzheimer's disease patients with depression than in those without depression. Dement Geriatr Cogn Disord 23, 231-240.
57. Tunnard C, Whitehead D, Hurt C, Wahlund LO, Mecocci P, Tsolaki M, Vellas B, Spenger C, Kloszewska I, Soininen H, Lovestone S, Simmons A (2011) Apathy and cortical atrophy in Alzheimer's disease. Int J Geriatr Psychiatry 26, 741-748.
58. Benoit M, Koulibaly PM,Migneco O, Darcourt J, Pringuey DJ, Robert PH (2002) Brain perfusion in Alzheimer's disease with and without apathy: A SPECT study with statistical parametric mapping analysis. Psychiatry Res 114, 103-111.
59. Marshall GA, Monserratt L, Harwood D, Mandelkern M, Cummings JL, Sultzer DL (2007) Positron emission tomography metabolic correlates of apathy in Alzheimer disease. Arch Neurol 64, 1015-1020.
60. ViciniChilovi B, Conti M, Zanetti M, Mazzu I, Rozzini L, Padovani A (2009) Differential impact of apathy and depression in the development of dementia in mild cognitive impairment patients. Dement Geriatr Cogn Disord 27, 390-398.
61. Palmer K, Di Iulio F,Varsi AE, GianniW, Sancesario G, Caltagirone C, Spalletta G (2010) Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: The role of depression and apathy. J Alzheimers Dis 20, 175-183.
62. Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K (2010) Biomarkers for Alzheimer's disease: Academic, industry and regulatory perspectives. Nat Rev Drug Discov 9, 560-574.
63. Weiser M, Garibaldi G (2015) Quantifying motivational deficits and apathy: A review of the literature. Eur Neuropsychopharmacol 25, 1060-1081.
64. Hoehn-Saric R, Harris GJ, Pearlson GD, Cox CS, Machlin SR, Camargo EE (1991) A fluoxetine-induced frontal lobe syndrome in an obsessive compulsive patient. J Clin Psychiatry 52, 131-133.
65. Hoehn-Saric R, Lipsey JR, McLeod DR (1990) Apathy and indifference in patients on fluvoxamine and fluoxetine. J Clin Psychopharmacol 10, 343-345.
66. George MS, Trimble MR (1992) A fluvoxamine-induced frontal lobe syndrome in a patient with comorbid Gilles de la Tourette's syndrome and obsessive compulsive disorder. J Clin Psychiatry 53, 379-380.
67. Barnhart WJ,Makela EH, LatochaMJ(2004) SSRI-induced apathy syndrome: A clinical review. J Psychiatr Pract 10, 196-199.
68. Padala PR, Padala KP,Monga V, Ramirez DA, Sullivan DH (2012) Reversal of SSRI-associated apathy syndrome by discontinuation of therapy. Ann Pharmacother 46, e8.
69. Harmer CJ, O'Sullivan U, Favaron E, Massey-Chase R, Ayres R, Reinecke A, Goodwin GM, Cowen PJ (2009) Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiatry 166, 1178-1184.
70. Browning M, Reid C, Cowen PJ, Goodwin GM, Harmer CJ (2007) A single dose of citalopram increases fear recognition in healthy subjects. J Psychopharmacol 21, 684-690.
71. Fu CH, Williams SC, Cleare AJ, Brammer MJ, Walsh ND, Kim J, Andrew CM, Pich EM, Williams PM, Reed LJ, Mitterschiffthaler MT, Suckling J, Bullmore ET (2004) Attenuation of the neural response to sad faces in major depression by antidepressant treatment: A prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 61, 877-889.